Could be true, but no.
As you said a couple of posts down (up?), MYX share price before the Teva announcement was some $1.40, after the announcement it quickly goes to $2. That's a 42% jump in both share price as well as the equivalent enterprise value.
i.e before Teva, MYX has some 810m shares. At $1.40 that's ev of $1.134B.
After Teva it has some 1.5b shares. That's ev of $1.5b. or 32% gain on the $1.40 share price at the current $1 price.
Could be true, but no. As you said a couple of posts down (up?...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.49 |
Change
-0.110(2.39%) |
Mkt cap ! $381.1M | |||
| Open | High | Low | Value | Volume |
| $4.60 | $4.67 | $4.47 | $600.2K | 132.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 5739 | $4.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.49 | 765 | 7 |
View Market Depth
| Last trade - 14.43pm 03/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |